Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis.
Saved in:
| Title: | Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis. |
|---|---|
| Authors: | Meric-Bernstam F; Department of Investigational Cancer Therapeutics (Phase I Program), MD Anderson Cancer Center, University of Texas, Houston, TX 77030, United States., Bardia A; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA 90095, United States., Bossi P; Department of Biomedical Sciences, Humanitas University, Milan 20072, Italy.; Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan 20089, Italy., Bianchini G; Department of Medical Oncology, San Raffaele Hospital, Milan 20132, Italy.; School of Medicine and Surgery, Università Vita-Salute San Raffaele, Milan 20132, Italy., Gatlin F; Virginia Cancer Specialists, Fairfax, VA 22031, United States., Lalla RV; Division of Oral Medicine, University of Connecticut School of Dental Medicine, Farmington, CT 06030, United States., Melosky B; British Columbia Cancer Agency, Vancouver V5Z 4E6, Canada., Niikura N; Department of Breast Oncology, Tokai University School of Medicine, Kanagawa 259-1193, Japan., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program), MD Anderson Cancer Center, University of Texas, Houston, TX 77030, United States., Kim SS; Clinical Safety and Pharmacovigilance, Daiichi Sankyo Inc., Basking Ridge, NJ 07920, United States., Rajagopalan R; Clinical Safety and Pharmacovigilance, Daiichi Sankyo UK Ltd, Uxbridge UB8 1DH, UK., Fairhurst RM; Patient Safety Oncology, AstraZeneca, Gaithersburg, MD 20878, United States., Graff SL; Lifespan Cancer Institute, Legorreta Cancer Center, Brown University, Providence, RI 02903, United States., Rugo HS; University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA 94115, United States. |
| Source: | The oncologist [Oncologist] 2025 Mar 10; Vol. 30 (3). |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyaf031 |
